Robert, who is the Principal at the communications and strategy consulting firm, RMG Associates, has more than 30 years of experience in the biotechnology and pharmaceutical industries as a consultant on strategy and communications, in-house communications director, and journalist. He has substantial experience and a strong track record in work with well over 100 companies and organizations ranging from start-ups in and outside of the U.S. to multi-nationals. Robert and RMG Associates bring particular expertise in corporate positioning, external and internal communications strategy, and preparation for financing and partnering. He has helped more than 20 clients develop business plans to support venture and public financings.
Robert co-founded Feinstein Kean Healthcare (now a division of Ogilvy Public Relations Worldwide), a Massachusetts-based communications and business consulting firm focused exclusively on biotechnology, pharmaceutical, and related healthcare organizations. Robert has been an active member of the biotechnology community in Massachusetts for more than 25 years. Robert served as an advisor to the Massachusetts Biotechnology Council for over 15 years. He also participates as a mentor in MIT’s Venture Mentoring Service and as a member of the Board of Directors of the New England Israel Business Council.
Robert holds a B.A. degree from Trinity College (Connecticut).
Kristin is a Consultant on the Program Management team at Avania Clinical, a global CRO focused on advancing medical devices, novel technology and combination products from feasibility through post-approval trials. Her team provides early stage strategic consulting services that include feasibility and benchmarking analysis, pre-clinical study design, and tailored regulatory strategies. Prior, as the Senior Program Development Manager for Life Science Strategic Initiatives at Worcester Polytechnic Institute, she led demand-driven program development in biotechnology, medicinal chemistry, biomedical and chemical engineering, and project management for technical symposia, research partnerships and consulting contracts with industry and government partners.
Kristin earned her B.S. in Chemical Engineering cum laude from Cornell University. After beginning her career in product design and development at Procter & Gamble and Arthur D. Little Inc., she then focused on her biotechnology interests with roles in process and project design engineering at Anika Therapeutics and Genzyme Corporation. She first partnered with the MassBioEd team during her tenure as WPI’s Associate Director of Pre-collegiate Outreach, and continues to support the valuable work the foundation does as a member of the Board and several program steering committees.
Amita is the Senior Director, Alliance Management at Intellia Therapeutics where she manages partnerships and alliances for Intellia. Prior to this role Amita was iAwards Scientific Program Director at Sanofi where she helped to launch and managed the Sanofi Innovation Awards (iAwards) Program, a partnership with academic centers and universities within North America to identify and fund translational research. During her time at Sanofi, Amita has also served as Director of Alliance Management where she supported several key drug discovery technology platform alliances including in computational drug design, small molecule drug discovery and antibody development across multiple therapeutic areas. Amita has 15 years of experience in biomedical & life sciences technology evaluation and managing academic-industry collaborations focused on translational research opportunities.
Amita started her career at Partners HealthCare Innovation where she where she managed research innovation portfolios across multiple departments at the Brigham & Women’s Hospital and supported intellectual property management, licensing and commercialization. Amita also helped in the formation of start-ups and licensing of foundational IP while also negotiating contracts that helped advance research at the Brigham through industry funding. Amita Joshi received her Ph.D. degree in Molecular Biology from the Tata Institute of Fundamental Research, Mumbai, India and has completed a postdoctoral fellowship in epigenetics and transcription biology in the laboratory of Dr. Kevin Struhl at Harvard Medical School.
Amita enjoys participating in initiatives that promote science education among students and the community and advancing promising life sciences technologies that aim to improve healthcare. She has served as a volunteer at the Museum of Science and is frequently a judge for MassChallenge competitions to evaluate and mentor innovative start-ups.
Wynter earned her B.S.E. in Bioengineering with a minor in Materials Science and Engineering at the University of Pennsylvania. Upon completion of her Ph.D. at Boston University in Biomedical engineering, she began a post-doc in Applied Physics at the Harvard Paulson School of Engineering. After her post-doc, she participated in developing a Western-style education and research system in a three-year-old University, Nazarbayev University (NU), in Kazakhstan in Central Asia.
Through research and teaching at NU, she was able to provide unprecedented access to a research-based engineering curriculum. She worked with a few students to found the first International Affiliate Student chapter of the Society of Women Engineers (SWE) in Central Asia. In her time as a lecturer at Boston University, she has been engaged in supporting students as the faculty advisor for the National Society of Black Engineers and building the graduate student pipeline through recruiting at National Affinity conferences. As the Assistant Dean of Outreach and Diversity, she is leading the College of Engineering at Boston University towards becoming a more diverse, equitable, and inclusive college for all, particularly those from traditionally underrepresented groups.
She has been actively increasing the graduate student pipeline by amplifying the College’s presence at conferences serving URG students, and creating a prospective student database from these conferences and through databases. In addition, she has been building our faculty pipeline through hosting research symposia in which post-docs and late stage graduate students are invited. To expand our impact and truly reach underrepresented populations worldwide, she has been developing partnerships with Minority Serving Institutions and other organizations worldwide. She has been developing partnerships with Minority Serving Institutions and other organizations to identify barriers inhibiting progress in inclusion.
Wynter has become the leader of the 9-year-old, Boston University (BU), College of Engineering undergraduate facilitated engineering outreach program, the Technology Innovation Scholars Program (TISP). Historically, BU’s undergraduates, “Inspiration Ambassadors” went into middle and high school classrooms educating and inspiring students about engineering and helping them complete mini-engineering activities, known as “Innovations in a Box”. In our new post-COVID world without physical classrooms, we have expanded and refined our reach by working with elementary schools and using a blended modality of remote and in-person learning. She has been working to increase access for engineering outreach for underserved populations in the greater Boston area.
Renee is the global head of Communications and Business Markets / Services at MilliporeSigma, where she leverages the power of education, community and responsibility to motivate the many people the company impacts to achieve greatness. In this role since 2013, Connolly leads the company’s internal communications for 22,000 employees, as well as its external communication, corporate brand strategy, community affairs and corporate responsibility programs. She also oversees events and programs for the business worldwide.
In 2015, Renee spearheaded the communication strategy for the $17 billion acquisition of chemical giant Sigma-Aldrich — marking the largest acquisition in the company’s history and one of the largest in the Life Science industry. During this time, she also launched MilliporeSigma’s SPARK™ global volunteer program and signature Curiosity Labs™ program, which inspires students to explore STEM careers through hands-on education. Since SPARK’s inception in early 2016, more than 9,700 MilliporeSigma employees have volunteered more than 89,400 hours across 36 countries, engaging more than 234,000 children.
Prior to joining MilliporeSigma, Renee served as vice president of U.S. Communications for EMD Serono. Before moving to Massachusetts, she spent nine years in New York City, working in public and investor relations in the biotechnology, pharmaceuticals and life sciences industries.
Renee enjoys contributing to organizations focused on building better communities, supporting young women professionals and encouraging future scientists and engineers. She is a board member of the Massachusetts Conference for Women, the Home for Little Wanderers and the Mass Women’s Forum. She has been involved in the American Cancer Society, Hope Lodge and the American Diabetes Association. She was a member of the MassBioEd Foundation for nearly 10 years — three of which she served as chairwoman. She is a past recipient of the Working Mother of the Year award from Working Mother Magazine.
Renee earned a bachelor’s degree in journalism from Ithaca College. She and her husband, Scott, are parents to four children and live in the Boston suburbs.
Ryan is a leading biotech executive with over 20 years of experience in driving early-stage drug development to commercial success. He is the President and Chief Operating Officer of Bicara Therapeutics, a private, clinical-stage oncology company developing bifunctional antibodies that combine the precision of well-validated, tumor-targeting antibodies with the power of immunomodulators for synergistic, durable impact at the site of the tumor.
Prior to Bicara, Ryan was a founding executive of Rheos Medicines, an immuno-metabolism company launched from Third Rock Ventures. Previous to that, Ryan was Vice President of Marketing, Operations and Analytics at Takeda Oncology where he was responsible for the company’s commercial oncology portfolio in the U.S. that included four compounds across a range of both Hematological and solid tumors.
Ryan holds a PharmD from Purdue University and is a current member of the Dean’s Advisory Council.
Debbie is the Chief People Officer at Blueprint Medicines. In this role she has responsibility for defining the organizations human resources strategy. She manages the overall delivery of human resources services, programs and policies (including workforce planning, employee relations, recruitment/staffing, performance management, leadership and development, compensation, benefits administration and organization development) in support of the organizations goals. Additionally, Debbie works closely with the Board of Directors, executive and management teams on change management initiatives as the organization experiences significant growth.
Debbie is involved in many community outreach activities associated with STEM education and served on the Corporate Giving Committee during her tenure as a HR leader at Cubist Pharmaceuticals prior to joining Blueprint Medicines.
In 2013, Debbie received the “Rising Star” award by Healthcare Business Women’s Association. Over the past three years, she has been published in C&EN magazine on multiple articles related to career and employment trends. Debbie earned a B.S. degree in Business Management from Bentley College and continues to be active with Alumni Relations by serving as a Mentor to the Emerging Leaders MBA program. Currently, she is a member of Healthcare Business Women’s Association (HBA), Human Resource Leadership Forum (HRLF) and Society of Human Resource Management (SHRM).